國立虎尾科技大學 |

Extremophilic Cyanobacteria For Novel Drug Development

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Extremophilic Cyanobacteria For Novel Drug Development/ by Sikha Mandal, Jnanendra Rath.
Author:	Mandal, Sikha.
other author:	Rath, Jnanendra.
Description:	VII, 92 p. 1 illus.online resource. :
Contained By:	Springer Nature eBook
Subject:	Pharmaceutical technology. -
Online resource:	https://doi.org/10.1007/978-3-319-12009-6
ISBN:	9783319120096

Extremophilic Cyanobacteria For Novel Drug Development
Mandal, Sikha.

Extremophilic Cyanobacteria For Novel Drug Development[electronic resource] /by Sikha Mandal, Jnanendra Rath. - 1st ed. 2015. - VII, 92 p. 1 illus.online resource. - SpringerBriefs in Pharmaceutical Science & Drug Development,1864-8118. - SpringerBriefs in Pharmaceutical Science & Drug Development,.

1 Introduction -- 2 Secondary Metabolites of Cyanobacteria and Drug Development -- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them -- 4 Anticancer Drug Development from Cyanobacteria -- 5 Issues and Challenges of Drug Development from Cyanobacteria.

This volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to diverse metabolic pathways, and the opportunity to use them to develop novel drugs. The book is comprised of five chapters, starting with the origin of cyanobacteria, their survival strategies under extreme conditions, and their capabilities to change metabolic activities.The second chapter explores the different metabolic pathways found in cyanobacteria and examines advances in this field and recent techniques like MALDI-TOF imaging and metagenomics tools as well as in silico techniques for rapid screening of secondary metabolites. Further chapters cover the glycomics of cyanobacteria, anticancer drug development, and some issues and challenges of using cyanobacteria to develop drugs. Extremophilic Cyanobacteria For Novel Drug Development provides insight into future perspectives in drug development and is a key resource for students, researchers and professionals in pharmacy, medicinal chemistry, pharmacognosy biotechnology, biology, and academics.

ISBN: 9783319120096

Standard No.: 10.1007/978-3-319-12009-6doiSubjects--Topical Terms:

557391
Pharmaceutical technology.

LC Class. No.: RS380

Dewey Class. No.: 615.19

Extremophilic Cyanobacteria For Novel Drug Development
LDR:02917nam a22004095i 4500 001 963706
003 DE-He213
005 20200702100723.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319120096 $9 978-3-319-12009-6
024 7 $a 10.1007/978-3-319-12009-6 $2 doi
035 $a 978-3-319-12009-6
050 4 $a RS380
050 4 $a RS190-210
072 7 $a TDCW $2 bicssc
072 7 $a MED072000 $2 bisacsh
072 7 $a TDC $2 thema
082 0 4 $a 615.19 $2 23
100 1 $a Mandal, Sikha. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1064674
245 1 0 $a Extremophilic Cyanobacteria For Novel Drug Development $h [electronic resource] / $c by Sikha Mandal, Jnanendra Rath.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a VII, 92 p. 1 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a SpringerBriefs in Pharmaceutical Science & Drug Development, $x 1864-8118
505 0 $a 1 Introduction -- 2 Secondary Metabolites of Cyanobacteria and Drug Development -- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them -- 4 Anticancer Drug Development from Cyanobacteria -- 5 Issues and Challenges of Drug Development from Cyanobacteria.
520 $a This volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to diverse metabolic pathways, and the opportunity to use them to develop novel drugs. The book is comprised of five chapters, starting with the origin of cyanobacteria, their survival strategies under extreme conditions, and their capabilities to change metabolic activities.The second chapter explores the different metabolic pathways found in cyanobacteria and examines advances in this field and recent techniques like MALDI-TOF imaging and metagenomics tools as well as in silico techniques for rapid screening of secondary metabolites. Further chapters cover the glycomics of cyanobacteria, anticancer drug development, and some issues and challenges of using cyanobacteria to develop drugs. Extremophilic Cyanobacteria For Novel Drug Development provides insight into future perspectives in drug development and is a key resource for students, researchers and professionals in pharmacy, medicinal chemistry, pharmacognosy biotechnology, biology, and academics.
650 0 $a Pharmaceutical technology. $3 557391
650 1 4 $a Pharmaceutical Sciences/Technology. $3 768561
700 1 $a Rath, Jnanendra. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1064675
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319120102
776 0 8 $i Printed edition: $z 9783319120089
830 0 $a SpringerBriefs in Pharmaceutical Science & Drug Development, $x 1864-8118 $3 1254821
856 4 0 $u https://doi.org/10.1007/978-3-319-12009-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)